Seguir
Wenhui Mao
Wenhui Mao
Duke Global Health Institute
Dirección de correo verificada de duke.edu
Título
Citado por
Citado por
Año
10 years of health-care reform in China: progress and gaps in Universal Health Coverage
W Yip, H Fu, AT Chen, T Zhai, W Jian, R Xu, J Pan, M Hu, Z Zhou, Q Chen, ...
The Lancet 394 (10204), 1192-1204, 2019
7272019
Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021
SW Hanson, C Abbafati, JG Aerts, Z Al-Aly, C Ashbaugh, T Ballouz, ...
Jama 328 (16), 1604-1615, 2022
491*2022
Systematic review on irrational use of medicines in China and Vietnam
W Mao, H Vu, Z Xie, W Chen, S Tang
PloS one 10 (3), e0117710, 2015
1972015
Complications of diabetes in China: health system and economic implications
W Mao, CMW Yip, W Chen
BMC public health 19, 1-11, 2019
1042019
It is not too late to achieve global covid-19 vaccine equity
G Yamey, P Garcia, F Hassan, W Mao, KK McDade, M Pai, S Saha, ...
Bmj 376, 2022
852022
Does economic incentive matter for rational use of medicine? China’s experience from the essential medicines program
M Chen, L Wang, W Chen, L Zhang, H Jiang, W Mao
Pharmacoeconomics 32, 245-255, 2014
662014
Current situation and progress toward the 2030 health-related Sustainable Development Goals in China: a systematic analysis
S Chen, L Guo, Z Wang, W Mao, Y Ge, X Ying, J Fang, Q Long, Q Liu, ...
PLoS medicine 16 (11), e1002975, 2019
652019
Financial burden of healthcare for cancer patients with social medical insurance: a multi-centered study in urban China
W Mao, S Tang, Y Zhu, Z Xie, W Chen
International journal for equity in health 16, 1-12, 2017
422017
Combating hepatitis B and C by 2030: achievements, gaps, and options for actions in China
S Chen, W Mao, L Guo, J Zhang, S Tang
BMJ global health 5 (6), e002306, 2020
362020
People's Republic of China health system review
World Health Organization
Health systems in transition 5 (7), 2015
362015
Improving Health System Efficiency: China Zero Mark-up for Essential Medicines at Primary Level Facilities
W Mao, W Chen
34*2015
Advancing universal health coverage in China and Vietnam: lessons for other countries
W Mao, Y Tang, T Tran, M Pender, PN Khanh, S Tang
BMC Public Health 20, 1-9, 2020
292020
Under-reporting of TB cases and associated factors: a case study in China
D Zhou, M Pender, W Jiang, W Mao, S Tang
BMC public health 19, 1-9, 2019
292019
Does health insurance impact health service utilization among older adults in urban China? A nationwide cross-sectional study
W Mao, Y Zhang, L Xu, Z Miao, D Dong, S Tang
BMC health services research 20, 1-9, 2020
242020
Does perverse economic incentive lead to the irrational uses of medicines?
W Mao, S Tang, W Chen
Expert review of pharmacoeconomics & outcomes research 13 (6), 693-696, 2013
232013
The impacts of donor transitions on health systems in middle-income countries: a scoping review
HE Huffstetler, S Bandara, I Bharali, K Kennedy Mcdade, W Mao, F Guo, ...
Health policy and planning 37 (9), 1188-1202, 2022
222022
Addressing child health inequity through case management of under-five malaria in Nigeria: an extended cost-effectiveness analysis
RR Dasgupta, W Mao, O Ogbuoji
Malaria Journal 21 (1), 81, 2022
202022
An analysis on rational use and affordability of medicine after the implementation of National Essential Medicines Policy and Zero Mark-up Policy in Hangzhou, China
W Mao, Y Huang, W Chen
PLoS One 14 (3), e0213638, 2019
202019
Did the poor gain from India’s health policy interventions? Evidence from benefit-incidence analysis, 2004–2018
S Selvaraj, AK Karan, W Mao, H Hasan, I Bharali, P Kumar, O Ogbuoji, ...
International journal for equity in health 20, 1-15, 2021
172021
COVID-19 control strategies in Taizhou city, China
NH Haijiang Lin, Congcong Guo, Yafei Hu, Hongbiao Liang, Shen Weiwei, Wenhui Mao
Bulletin of the World Health Organisation 98 (9), 632-637, 2020
17*2020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20